R
Regeneron Pharmaceuticals, Inc. (REGN)
NMS – Real vaqt narxi. Valyuta: USD
723.41
+10.64 (1.49%)
Yopilishda: May 12, 2026, 4:00 PM EDT
722.99
-0.42 (-0.06%)
Bozor oldidan: May 13, 2026, 4:34 AM EDT
Find any stock by ticker or company name

NMS – Real vaqt narxi. Valyuta: USD
723.41
+10.64 (1.49%)
Yopilishda: May 12, 2026, 4:00 PM EDT
722.99
-0.42 (-0.06%)
Bozor oldidan: May 13, 2026, 4:34 AM EDT
This stock has a consensus price target of $854.13 based on the ratings of 31 analysts. The high is $1150.00 and the low is $587.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 587 | $ 854.13 | $ 1150 |
| O’zgarish | -17.65% | 19.83% | 61.34% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-04-23 | 33.44% | TD Cowen | $880 → $960 | Maintains | Buy |
| 2026-04-23 | 11.2% | Cantor Fitzgerald | $800 → $800 | Reiterates | Overweight |
| 2026-04-10 | 10.64% | Morgan Stanley | $769 → $796 | Maintains | Equal-Weight |
| 2026-04-08 | 28.02% | Bernstein | $925 → $921 | Maintains | Outperform |
| 2026-03-31 | 21.63% | Piper Sandler | $875 | Assumes | Overweight |